Published in Glycoconj J on November 13, 2008
Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites. J Trop Med (2011) 0.91
Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis (2004) 11.90
Advances in leishmaniasis. Lancet (2005) 8.95
Regulatory T cells in the control of immune pathology. Nat Immunol (2001) 6.98
CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med (2003) 6.00
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (1994) 4.38
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis (2000) 3.72
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol (1993) 3.30
Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2002) 3.21
Leishmaniasis: current status of vaccine development. Clin Microbiol Rev (2001) 2.62
An analysis of T cell responsiveness in Indian kala-azar. J Immunol (1987) 2.56
Immunology of leishmaniasis. Adv Parasitol (1993) 2.16
Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev (2004) 2.12
Second-generation vaccines against leishmaniasis. Trends Parasitol (2005) 1.99
Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci U S A (1995) 1.99
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet (2000) 1.86
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg (1992) 1.83
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet (1998) 1.81
The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J Immunol (2001) 1.78
IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol (1995) 1.69
Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect Immun (1994) 1.62
Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J Exp Med (1997) 1.59
Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrob Agents Chemother (2003) 1.45
Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother (2001) 1.39
Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res (2006) 1.39
Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy. Am J Trop Med Hyg (1990) 1.37
Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony. J Infect Dis (1988) 1.35
Murine MHC polymorphism and T cell specificities. Science (1989) 1.34
In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol (2000) 1.21
Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol (2008) 1.12
Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun (2005) 1.09
Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun (2003) 1.06
Immunization of susceptible BALB/c mice against Leishmania braziliensis. I. Resistance induced using as immunogen adherent or nonadherent cells from infected mice. Cell Immunol (1985) 1.02
Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin Exp Immunol (1991) 1.02
Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp Parasitol (2001) 1.01
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination. Infect Immun (2002) 1.00
Analysis of lectin-dependent recognition of desialylated erythrocytes by Kupffer cells. Biochem J (1980) 0.99
Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine (1999) 0.97
Recent developments in the chemotherapy of leishmaniasis. Trends Pharmacol Sci (1988) 0.97
Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines. J Infect Dis (2003) 0.95
Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes. Am J Trop Med Hyg (1981) 0.90
Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis. Clin Diagn Lab Immunol (2000) 0.90
Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. Eur J Immunol (1999) 0.87
New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice. Microbes Infect (1999) 0.86
Induction of cell-mediated immunity during early stages of infection with intracellular protozoa. Braz J Med Biol Res (1998) 0.85
Leishmania vaccines: old and new. Parasitol Today (1997) 0.82
Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence. J Parasitol (1999) 0.82
Leishmania mexicana H-line attenuated under pressure of gentamicin, potentiates a Th1 response and control of cutaneous leishmaniasis in BALB/c mice. Parasite Immunol (2004) 0.80
Virulence attenuation of a UDP-galactose/N-acetylglucosamine beta1,4 galactosyltransferase expressing Leishmania donovani promastigote. Glycoconj J (2008) 0.75
Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani. Antimicrob Agents Chemother (2011) 1.45
Laparoscopic management of juvenile cystic adenomyoma: four cases. J Minim Invasive Gynecol (2011) 1.10
Primary melanoma of the urethra: a rare neoplasm of the urinary tract. Int Urol Nephrol (2007) 1.04
Solitary malignant schwannoma of the nasal cavity and paranasal sinuses: report of two rare cases. Ear Nose Throat J (2003) 0.89
Self-assembly of tetramers of 5,6-dihydroxyindole explains the primary physical properties of eumelanin: experiment, simulation, and design. ACS Nano (2013) 0.87
TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasis. PLoS Pathog (2012) 0.87
Crystal structure of glutamyl-queuosine tRNAAsp synthetase complexed with L-glutamate: structural elements mediating tRNA-independent activation of glutamate and glutamylation of tRNAAsp anticodon. J Mol Biol (2008) 0.87
Large-area high-throughput synthesis of monolayer graphene sheet by Hot Filament Thermal Chemical Vapor Deposition. Sci Rep (2012) 0.86
Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. Infect Immun (2007) 0.86
Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. Int Urol Nephrol (2010) 0.85
In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate. Clin Vaccine Immunol (2010) 0.84
115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity. Immunobiology (2012) 0.83
Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Eur J Immunol (2009) 0.81
Solitary eosinophilic granuloma of the radius. An unusual differential diagnosis. Acta Orthop Belg (2007) 0.81
Mechanism of action of novel synthetic dodecapeptides against Candida albicans. Biochim Biophys Acta (2013) 0.81
Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages. Eur J Immunol (2011) 0.81
TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis. Eur J Immunol (2012) 0.80
In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity. Exp Parasitol (2013) 0.80
Papillary cystadenocarcinomas of salivary glands with oncocytic epithelial lining: report of 2 cases. Int J Surg Pathol (2008) 0.79
T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells. J Neurooncol (2013) 0.78
Isolation, characterization, and EGFP expression in the buffalo (Bubalus bubalis) mammary gland epithelial cell line. In Vitro Cell Dev Biol Anim (2012) 0.78
Antiproteolytic and leishmanicidal activity of Coccinia grandis (L.) Voigt leaf extract against Leishmania donovani promastigotes. Indian J Exp Biol (2015) 0.78
Protease inhibitors in potential drug development for Leishmaniasis. Indian J Biochem Biophys (2013) 0.77
Immunolocalization and characterization of two novel proteases in Leishmania donovani: putative roles in host invasion and parasite development. Biochimie (2010) 0.77
Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes. Mol Biochem Parasitol (2006) 0.77
Construction of a recombinant human insulin expression vector for mammary gland-specific expression in buffalo (Bubalus bubalis) mammary epithelial cell line. Mol Biol Rep (2014) 0.77
Identification, purification, and characterization of a secretory serine protease in an Indian strain of Leishmania donovani. Mol Cell Biochem (2008) 0.77
Immuno stimulating glycophosphosphingolipid antigen from Leishmania donovani is recognized by visceral leishmaniasis patient sera. Mol Biochem Parasitol (2008) 0.77
Leishmania donovani secretory serine protease alters macrophage inflammatory response via COX-2 mediated PGE-2 production. Indian J Biochem Biophys (2014) 0.76
Effect of different serine protease inhibitors in validating the 115 kDa Leishmania donovani secretory serine protease as chemotherapeutic target. Indian J Biochem Biophys (2015) 0.76
TLR4-mediated activation of MyD88 signaling induces protective immune response and IL-10 down-regulation in Leishmania donovani infection. Indian J Biochem Biophys (2014) 0.75
Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains. J Antimicrob Chemother (2012) 0.75
Dextrocardia and asplenia in situs inversus totalis in a baby: a case report. J Med Case Rep (2014) 0.75
An unusual nail presentation in Marfan's syndrome. J Dermatol (2002) 0.75
Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells. Cell Immunol (2013) 0.75
Bioactivity guided fractionation of Moringa oleifera Lam. flower targeting Leishmania donovani. Indian J Exp Biol (2015) 0.75
Immunomodulatory role of TIITS in respect to cytotoxic lymphocytes in four grades of human glioma. Cell Immunol (2012) 0.75
The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation. J Neurooncol (2014) 0.75
Morphometric study of lymphoid cells in mycosis fungoides and its simulators. Indian J Pathol Microbiol (2003) 0.75
Characteristic analysis of aspheric quasi-optical lens antenna in millimeter-wave radiometer imaging system. Appl Opt (2013) 0.75
Effect of physico-chemical treatments on ripening behavior and post-harvest quality of Amrapali mango (Mangifera indica L.) during storage. J Environ Biol (2012) 0.75
Deeply eosinophilic cell variant of signet-ring type of gastric carcinoma: a diagnostic dilemma. Int J Clin Oncol (2008) 0.75
Therapeutic profile of T11TS vs. T11TS+MiADMSA: a hunt for a more effective therapeutic regimen for arsenic exposure. Asian Pac J Cancer Prev (2012) 0.75
Real time PCR in childhood tuberculosis: a valuable diagnostic tool. Indian J Pediatr (2014) 0.75
Comparison of synthetic dopamine-eumelanin formed in the presence of oxygen and Cu2+ cations as oxidants. Langmuir (2013) 0.75